MDxHealth SA Ordinary Shares
MDXH Real Time Price USDRecent trades of MDXH by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by MDXH's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Method for predicting and treating clinically significant prostate cancer Sep. 26, 2023
-
Patent Title: Methods and kits for identifying and adjusting for bias in sequencing of polynucleotide samples Nov. 06, 2018
-
Patent Title: Method for determining the methylation status of the promoter region of the twist1 gene in genomic dna from bladder cells Oct. 30, 2018
-
Patent Title: Methylation detection of the mgmt promoter Aug. 21, 2018
-
Patent Title: Methods of detecting mutations in braf and epigenetic changes Mar. 28, 2017
-
Patent Title: Methylation of the gata4 gene in urine samples as a marker for bladder cancer detection Jul. 12, 2016
-
Patent Title: Methods for determining methylation of the twist1 gene for bladder cancer detection Apr. 26, 2016
-
Patent Title: Methylation detection of mgmt Jun. 09, 2015
-
Patent Title: Methods for detecting epigenetic modifications Mar. 03, 2015
-
Patent Title: Detection of mage-a expression Jul. 09, 2013
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of MDXH in WallStreetBets Daily Discussion
Recent insights relating to MDXH
Recent picks made for MDXH stock on CNBC
ETFs with the largest estimated holdings in MDXH
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view MDXH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.